Cytodyn Inc (CYDY)

[Apollo_]

Will someone PLEASE step up and challenge Gilead

Gilead now serves about 85% of treated HIV patients in the United States... we think Gilead's HIV franchise will peak at $11.7 billion in 2018 .... If Gilead's HIV franchise does not maintain its superior efficacy and safety status, a large portion of its sales foundation could be at risk

http://analysisreport.morningstar.com/stock/research?t=GILD®ion=usa&culture=en-US&productcode=MLE


Gilead simply mixes, matches and tweaks their same old drugs to extend patent life and increase price... it's time for a serious paradigm shift in HIV treatment.

Something that can be self administered and will last weeks or even MONTHS at a time ... something that isn't just another a toxic, EXPENSIVE drug. Something that actually works with the immune system making a big-time improvement in a patient's quality of life.